Home › IGA Glomerulonephritis › Pennsylvania › Philadelphia
IGA Glomerulonephritis clinical trials in Philadelphia, PA
3 studies for IGA Glomerulonephritis are looking for participants at sites in and around Philadelphia (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)
RecruitingPhase 3
- Penn Renal Electrolyte and Hypertension Perelman, Philadelphia
Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Iptacopan in Pediatric Patients With Primary IgAN
RecruitingPhase 3
- Childrens Hospital of Philadelphia, Philadelphia
Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
RecruitingPhase 2
- Children's Hospital of Philadelphia, Philadelphia
- Nemours Children's Hospital, Wilmington · 25 mi away
IGA Glomerulonephritis trials in other cities
- Houston, TX9 studies
- Denver, CO5 studies
- Orlando, FL5 studies
- Los Angeles, CA4 studies
- Sioux City, IA4 studies
- Cedar Rapids, IA3 studies
- Boston, MA3 studies
- New York City, NY3 studies
- Johns Creek, GA3 studies
- Columbus, OH3 studies
Other studies in Philadelphia
- Cancer (all types)60 studies
- Breast Cancer56 studies
- Non-Small Cell Lung Cancer51 studies
- Metastatic Cancer46 studies
- Colorectal Cancer44 studies
- Ovarian Cancer44 studies
- Prostate Cancer44 studies
- Lung Cancer36 studies
- Acute Myeloid Leukemia34 studies
- Heart Failure31 studies
- Endometrial Cancer29 studies
- Pancreatic Cancer26 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.